News

New publication our immune system: a guardian, mediator, and betrayer

- The new publication by Biosciences and Society (Biowetenschappen en Maatschappij) explains all about our immune system and how it can guards, mediates or betrays us. The interesting patient perspectives on autoimmune diseases brings the story of the immune system to life.

Health~Holland introduce the Innovation Broker in collaboration with MedtechPartners

- MedtechPartners and Health~Holland introduce a new tool to support start-ups and SMEs. The new tool, called Innovation Broker, provides guidance for companies for their innovation process, the development of a business case or support with market introduction. A great tool to get access to specialised consultative support to help grow your business.

Survey on new journalistic platform for life sciences

- Onderzoeksbureau Motivaction onderzoekt of er behoefte bestaat aan een onafhankelijk journalistiek medium dat zich speciaal richt op mensen die werken in of met biotech, medtech, farma en e-health.

FDA approves first-of-its kind targeted RNA-based therapy

- The FDA approved Alnylam's patisiran for the treatment of peripheral nerve disease (polyneuropathy), caused by hereditary transthyretin-mediated amyloidosis (hATTR). It is the first FDA approval of a new class of drugs called small interfering ribonucleic acid (siRNA) treatment.

Open call for Oncode investigator applications

- Oncode Institute has opened a call for applications for their Oncode Recruitment Programme. Up to eleven scientists will be awarded base-funding for the remaining duration of the first phase of Oncode, ending in September 2022.

Big Data & Health call open for application

- Gezamenlijk met NWO, ZonMw, de Hartstichting, ministerie VWS en het Netherlands eScience Center, Topsector ICT en Creatieve Industrie lanceert de Top Sector LSH (Health~Holland) het PPS-onderzoeksprogramma Big Data & Gezondhheid. Dit programma is nu open voor aanvragen.

Module Clinical Development

- The module Clinical Development at Paul Janssen Futurelab Leiden provides learning-by-doing training to ambitious -postgraduate biomedical researchers. During this program, you will further your career and increase your knowledge on the optimal development of novel medical interventions, using real life cases. Ready to go on-campus?

Top Sector LSH and SGF invest 15 million in immunology research

- De Samenwerkende Gezondheidsfondsen (SGF), waarin 20 gezondheidsfondsen waaronder KWF Kankerbestrijding en ReumaNederland de krachten hebben gebundeld, investeren samen met Topsector Life Sciences & Health (Health~Holland) en het bedrijfsleven 15 miljoen euro in veelbelovende immunologische onderzoeken. De onderzoeken moeten de werking van het menselijke afweersysteem verder ontrafelen.

Health & Care officially assigned as central theme in the mission driven innovation policy

- On 13 July the Ministerial Council officially approved the new Mission Driven Innovation Policy that builds upon the Top Sector Policy, with a clear focus on global societal challenges. Health & Care is appointed as one of the four central themes in the renewed Top Sector Policy. Top Sector Life Sciences & Health (LSH) celebrates this good news for the Dutch LSH sector. The importance of this sector and the strong innovative solutions it offers are now officially recognised by the government.

GlobalStars stimulating market-oriented R&D with partners outside Europe

- Bent u bezig met het ontwikkelen van technologie voor nieuwe producten, processen of diensten? Werkt u daarbij samen met partners buiten Europa? Dan is GlobalStars mogelijk iets voor u.